Latest Cardiovascular Disease (CVD) News
Study points to need for better coordinated care, more effective use of medications.
Those with type 2 diabetes and heart disease as well as a prior cardiovascular event have an increased risk of cardiovascular mortality.
Odds of cardiovascular mortality 14.8% higher in black Americans with both conditions.
For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks.
There was also a 22% reduction in the development of renal outcomes with liraglutide compared to placebo.
When taken in higher-than-recommended amounts, loperamide can cause cardiovascular conditions.
Coronary artery disease before transplantation increases death risk by 77%, study finds.
Patients exposed to high levels of air pollution have an elevated risk of cardiovascular disease.
The researchers found no relationship between poor quality of life and CKD progression.
The FDA has developed 2- and 10-year goals to reduce sodium content in both processed and prepared foods.
Increased risk for cardiovascular events and all-cause mortality for patients with type 2 diabetes.
Renal function decline is independent factor for cardiovascular risk in patients with type 2 diabetes.
One in 4 MI survivors develop heart failure within 4 years.
Cardiovascular disease risk is elevated when low HDL-C was accompanied by LDL-C and triglycerides.
CKD patients with daily sodium above 4,548 mg may help protect their cardiovascular health by reducing sodium in their diets, researchers suggested.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)